The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer. [electronic resource]
Producer: 20021001Description: 49-57 p. digitalISSN:- 1568-0096
- Animals
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Clinical Trials as Topic
- Drug Design
- Drug Evaluation
- Enzyme Inhibitors -- therapeutic use
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Piperazines -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.